NVAX ALERT - Nationally Ranked Shareholder Rights Firm Labaton Sucharow is Investigating Novavax, Inc. (NASDAQ:NVAX) for Potential Securities Violations
Back to Newsroom
Mentioned in this Article

NVAX ALERT - Nationally Ranked Shareholder Rights Firm Labaton Sucharow is Investigating Novavax, Inc. (NASDAQ:NVAX) for Potential Securities Violations

Friday, October 22, 2021 11:00 AM
Share this article now
Topic:
Lawsuits
Labaton Sucharow LLP

NEW YORK, NY / ACCESSWIRE / October 22, 2021 / Labaton Sucharow, a nationally ranked and award-winning shareholder rights law firm, is investigating potential violations of the federal securities laws by Novavax, Inc. (NASDAQ:NVAX).

On October 19, 2021, after the market closed, Politico published an article titled, "'They Rushed the Process': Vaccine Maker's woes hamper global inoculation campaign," alleging manufacturing and purity problems in Novavax's process to produce Covid-19 vaccinations for COVAX, an international consortium working to provide two billion doses to middle- and low-income countries. Previously, the U.S. government invested $1.6B in Novavax in 2020, the most devoted to any vaccine manufacturer at the time.

On this news shares of Novavax fell over 20% in premarket trading on October 20, 2021.

If you currently own stock or options in Novavax, Inc. and suffered a loss, click here to participate.

If you want to receive additional information and protect your investments free of charge, please contact David J. Schwartz using the toll-free number (800) 321-0476 or via email at [email protected].

About the Firm

Labaton Sucharow LLP is one of the world's leading complex litigation firms representing clients in securities, antitrust, corporate governance and shareholder rights, and consumer cybersecurity and data privacy litigation. Labaton Sucharow has been recognized for its excellence by the courts and peers, and it is consistently ranked in leading industry publications. Offices are located in New York, NY, Wilmington, DE, and Washington, D.C. More information about Labaton Sucharow is available at Labaton.com.

CONTACT:

David J. Schwartz
(800) 321-0476
[email protected]

SOURCE: Labaton Sucharow LLP

Back to Newsroom
Copyright 2022 © ACCESSWIRE. All rights reserved. Privacy Policy  |   Terms and Conditions